When the best is the enemy of the good: The case of bone-marrow mononuclear cells to treat ischemic syndromes

INMACULADA CONCEPCIÓN HERRERA ARROYO2026-01-292026-01-29201310.3324/haematol.2013.0862312-s2.0-84874532656https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/24393HematologyHematologyWhen the best is the enemy of the good: The case of bone-marrow mononuclear cells to treat ischemic syndromeseditorial